Sandra Lesenfants has broad commercial strategy experience and global business management skills gained from her senior executive roles at the vascular businesses at Medtronic, Covidien, EV3, and Siemens Healthcare. She has led several key integrations including the acquisition of Sapheon and its VenaSeal closure system, the integration of endoVenous business from Covidien's Vascular Therapy business into Medtronic, and the integration of the embolization sales team from Medtronic's Neurovascular division into endoVenous.
Mrs Lesenfants is a board member of The American Venous Forum Foundation.